TARDBP and amyotrophic lateral sclerosis: TARDBP mutation exhibited the slowest ALS progression (ALSPR mean 0.53, SD 0.52) with 69.6% of patients in the slower ALS progression category, followed by 21.8% intermediate, and 8.7% faster progressing ALS.